Autolus is ready to hit the ground running after winning FDA approval for its Aucatzyl ... U.K. site dubbed “the Nucleus” with Cardinal Health serving as the U.S. commercial distribution partner.
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the U ...
With new approvals on the horizon and the closely watched Casgevy launch picking up steam in sickle cell disease and beta ...